Role of ubiquitination and proteolysis in the regulation of pro- and anti-apoptotic TNF-R1 signaling

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1864, Issue 11, 2017, Pages 2138-2146

  Fritsch, Jürgen ^a   Zingler, Philipp ^a   Särchen, Vinzenz ^a   Heck, Anna Laura ^a   Schütze, Stefan ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

Apoptosis; Proteolysis; Receptor compartmentalization; TNF; TNF receptor 1; Ubiquitination

Indexed keywords

CASPASE; CASPASE 7; CASPASE 8; FAS LIGAND; PROTEINASE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; MEMBRANE PROTEIN;

APOPTOSIS; ARTICLE; CELL DEATH; CELL MEMBRANE; CYTOPLASM; ENDOSOME; HUMAN; INTRACELLULAR SIGNALING; LYSOSOME; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION; UBIQUITINATION; ENDOCYTOSIS; GENETICS; METABOLISM; ULTRASTRUCTURE;

APOPTOSIS; CELL MEMBRANE; ENDOCYTOSIS; HUMANS; LYSOSOMES; MEMBRANE PROTEINS; PROTEOLYSIS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SIGNAL TRANSDUCTION; UBIQUITINATION;

EID: 85026730522     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2017.07.017     Document Type: Article

References (101)

1. Cendrowski, J., Maminska, A., Miaczynska, M., Endocytic regulation of cytokine receptor signaling. Cytokine Growth Factor Rev., 2016.
2. Dobrowolski, R., De Robertis, E.M., Endocytic control of growth factor signalling: multivesicular bodies as signalling organelles. Nat. Rev. Mol. Cell Biol. 13:1 (2011), 53–60.
3. Barbieri, E., Di Fiore, P.P., Sigismund, S., Endocytic control of signaling at the plasma membrane. Curr. Opin. Cell Biol. 39 (2016), 21–27.
4. Irannejad, R. et al., Effects of endocytosis on receptor-mediated signaling. Curr. Opin. Cell Biol. 35 (2015), 137–143.
5. Ali, M. et al., Altering the sphingolipid acyl chain composition prevents LPS/GLN-mediated hepatic failure in mice by disrupting TNFR1 internalization. Cell Death Dis., 4, 2013, e929.
6. Edelmann, B. et al., Caspase-8 and caspase-7 sequentially mediate proteolytic activation of acid sphingomyelinase in TNF-R1 receptosomes. EMBO J. 30:2 (2011), 379–394.
7. Fritsch, J. et al., TNF induced cleavage of HSP90 by cathepsin D potentiates apoptotic cell death. Oncotarget 7:46 (2016), 75774–75789.
8. Fritsch, J. et al., Cell fate decisions to TNF regulated by K63 ubiquitination of TNF-receptor 1. Mol. Cell. Biol., 2014.
9. Liao, W. et al., Response: CARP1 regulates induction of NF-κB by TNFα. Curr. Biol. 19:1 (2009), R17–R19.
10. Liao, W. et al., CARP-2 is an endosome-associated ubiquitin ligase for RIP and regulates TNF-induced NF-kappaB activation. Curr. Biol. 18:9 (2008), 641–649.
11. Schneider-Brachert, W. et al., Inhibition of TNF receptor 1 internalization by adenovirus 14.7K as a novel immune escape mechanism. J. Clin. Invest. 116:11 (2006), 2901–2913.
12. Schneider-Brachert, W. et al., Compartmentalization of TNF receptor 1 signaling: internalized TNF receptosomes as death signaling vesicles. Immunity 21:3 (2004), 415–428.
13. Schütze, S., Tchikov, V., Schneider-Brachert, W., Regulation of TNFR1 and CD95 signalling by receptor compartmentalization. Nat. Rev. Mol. Cell Biol. 9:8 (2008), 655–662.
14. Stephan, M. et al., Role of caspases in CD95-induced biphasic activation of acid sphingomyelinase. Oncotarget, 2017.
15. Yazdanpanah, B. et al., Riboflavin kinase couples TNF receptor 1 to NADPH oxidase. Nature 460:7259 (2009), 1159–1163.
16. Schütze, S. et al., Inhibition of receptor internalization by monodansylcadaverine selectively blocks p55 tumor necrosis factor receptor death domain signaling. J. Biol. Chem. 274:15 (1999), 10203–10212.
17. Waguia Kontchou, C. et al., Infection of epithelial cells with Chlamydia trachomatis inhibits TNF-induced apoptosis at the level of receptor internalization while leaving non-apoptotic TNF-signalling intact. Cell. Microbiol. 18:11 (2016), 1583–1595.
18. Rauert, H. et al., TNFR1 and TNFR2 regulate the extrinsic apoptotic pathway in myeloma cells by multiple mechanisms. Cell Death Dis., 2, 2011, e194.
19. Rothe, M. et al., A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 78:4 (1994), 681–692.
20. Rothe, M. et al., The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell 83:7 (1995), 1243–1252.
21. Wajant, H., Scheurich, P., TNFR1-induced activation of the classical NF-kappaB pathway. FEBS J. 278:6 (2011), 862–876.
22. Fischer, R. et al., Ligand-induced internalization of TNF receptor 2 mediated by a di-leucin motif is dispensable for activation of the NFkappaB pathway. Cell. Signal. 23:1 (2011), 161–170.
23. Faustman, D., Davis, M., TNF receptor 2 pathway: drug target for autoimmune diseases. Nat. Rev. Drug Discov. 9:6 (2010), 482–493.
24. Black, R.A. et al., A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 385:6618 (1997), 729–733.
25. Black, R.A., Tumor necrosis factor-alpha converting enzyme. Int. J. Biochem. Cell Biol. 34:1 (2002), 1–5.
26. Bell, J.H. et al., Role of ADAM17 in the ectodomain shedding of TNF-alpha and its receptors by neutrophils and macrophages. J. Leukoc. Biol. 82:1 (2007), 173–176.
27. Reiss, K., Saftig, P., The “a disintegrin and metalloprotease” (ADAM) family of sheddases: physiological and cellular functions. Semin. Cell Dev. Biol. 20:2 (2009), 126–137.
28. Fluhrer, R. et al., A gamma-secretase-like intramembrane cleavage of TNFalpha by the GxGD aspartyl protease SPPL2b. Nat. Cell Biol. 8:8 (2006), 894–896.
29. Friedmann, E. et al., SPPL2a and SPPL2b promote intramembrane proteolysis of TNFalpha in activated dendritic cells to trigger IL-12 production. Nat. Cell Biol. 8:8 (2006), 843–848.
30. Mentrup, T. et al., A cell-based assay reveals nuclear translocation of intracellular domains released by SPPL proteases. Traffic 16:8 (2015), 871–892.
31. Peck, R., Brockhaus, M., Frey, J.R., Cell surface tumor necrosis factor (TNF) accounts for monocyte- and lymphocyte-mediated killing of TNF-resistant target cells. Cell. Immunol. 122:1 (1989), 1–10.
32. Perez, C. et al., A nonsecretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-to-cell contact. Cell 63:2 (1990), 251–258.
33. Grell, M. et al., Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF-R1 activation by endogenous membrane-anchored TNF. EMBO J. 18:11 (1999), 3034–3043.
34. Jiang, Y. et al., STAT1 mediates transmembrane TNF-alpha-induced formation of death-inducing signaling complex and apoptotic signaling via TNFR1. Cell Death Differ. 24:4 (2017), 660–671.
35. Nicolaou, A. et al., Adam17 deficiency promotes atherosclerosis by enhanced TNFR2 signaling in mice. Arterioscler. Thromb. Vasc. Biol. 37:2 (2017), 247–257.
36. Sommer, A. et al., Extracellular sphingomyelinase activity impairs TNF-alpha-indiced endothelial cell death via ADAM17 activation and TNF receptor 1 shedding. Oncotarget, 2017.
37. Chhibber-Goel, J. et al., gamma-Secretase activity is required for regulated intramembrane proteolysis of tumor necrosis factor (TNF) receptor 1 and TNF-mediated pro-apoptotic signaling. J. Biol. Chem. 291:11 (2016), 5971–5985.
38. Zinngrebe, J. et al., Ubiquitin in the immune system. EMBO Rep. 15:1 (2014), 28–45.
39. Dondelinger, Y. et al., Poly-ubiquitination in TNFR1-mediated necroptosis. Cell. Mol. Life Sci. 73:11–12 (2016), 2165–2176.
40. Varfolomeev, E., Vucic, D., Intracellular regulation of TNF activity in health and disease. Cytokine, 2016.
41. Witt, A., Vucic, D., Diverse ubiquitin linkages regulate RIP kinases-mediated inflammatory and cell death signaling. Cell Death Differ., 2017.
42. Peltzer, N., Darding, M., Walczak, H., Holding RIPK1 on the ubiquitin leash in TNFR1 signaling. Trends Cell Biol., 2016.
43. Tchikov, V., Fritsch, J., Schütze, S., Separation of magnetically isolated TNF receptosomes from mitochondria. Methods Enzymol. 535 (2014), 327–349.
44. Steinhäuser, C. et al., Immunomagnetic isolation of pathogen-containing phagosomes and apoptotic blebs from primary phagocytes. Curr. Protoc. Immunol., 105, 2014 (p. 14 36 1-14 36 26).
45. Steinhäuser, C. et al., Lipid-labeling facilitates a novel magnetic isolation procedure to characterize pathogen-containing phagosomes. Traffic 14:3 (2013), 321–336.
46. Legler, D.F. et al., Recruitment of TNF receptor 1 to lipid rafts is essential for TNFalpha-mediated NF-kappaB activation. Immunity 18:5 (2003), 655–664.
47. Lotocki, G. et al., Tumor necrosis factor receptor 1 and its signaling intermediates are recruited to lipid rafts in the traumatized brain. J. Neurosci. 24:49 (2004), 11010–11016.
48. Doan, J.E., Windmiller, D.A., Riches, D.W., Differential regulation of TNF-R1 signaling: lipid raft dependency of p42mapk/erk2 activation, but not NF-kappaB activation. J. Immunol. 172:12 (2004), 7654–7660.
49. Gao, S. et al., RNF8 negatively regulates NF-kappaB signaling by targeting IkappaB kinase: implications for the regulation of inflammation signaling. Biochem. Biophys. Res. Commun., 2017.
50. Wagner, S.A. et al., SPATA2 links CYLD to the TNF-alpha receptor signaling complex and modulates the receptor signaling outcomes. EMBO J. 35:17 (2016), 1868–1884.
51. Draber, P. et al., LUBAC-recruited CYLD and A20 regulate gene activation and cell death by exerting opposing effects on linear ubiquitin in signaling complexes. Cell Rep. 13:10 (2015), 2258–2272.
52. Wertz, I.E., Dixit, V.M., Regulation of death receptor signaling by the ubiquitin system. Cell Death Differ. 17:1 (2010), 14–24.
53. Shembade, N. et al., The E3 ligase Itch negatively regulates inflammatory signaling pathways by controlling the function of the ubiquitin-editing enzyme A20. Nat. Immunol. 9:3 (2008), 254–262.
54. Lork, M., Verhelst, K., Beyaert, R., CYLD, A20 and OTULIN deubiquitinases in NF-kappaB signaling and cell death: so similar, yet so different. Cell Death Differ., 2017.
55. Peter, M.E., Krammer, P.H., The CD95(APO-1/Fas) DISC and beyond. Cell Death Differ. 10:1 (2003), 26–35.
56. Mahul-Mellier, A.L. et al., Alix, making a link between apoptosis-linked gene-2, the endosomal sorting complexes required for transport, and neuronal death in vivo. J. Neurosci. 26:2 (2006), 542–549.
57. Mahul-Mellier, A.L. et al., Alix and ALG-2 make a link between endosomes and neuronal death. Biochem. Soc. Trans. 37:Pt 1 (2009), 200–203.
58. Mahul-Mellier, A.L. et al., Alix and ALG-2 are involved in tumor necrosis factor receptor 1-induced cell death. J. Biol. Chem. 283:50 (2008), 34954–34965.
59. Dowlatshahi, D.P. et al., ALIX is a Lys63-specific polyubiquitin binding protein that functions in retrovirus budding. Dev. Cell 23:6 (2012), 1247–1254.
60. Micheau, O., Tschopp, J., Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114:2 (2003), 181–190.
61. Meng, X.W. et al., High cell surface death receptor expression determines type I versus type II signaling. J. Biol. Chem. 286:41 (2011), 35823–35833.
62. Jost, P.J. et al., XIAP discriminates between type I and type II FAS-induced apoptosis. Nature 460:7258 (2009), 1035–1039.
63. Kurita, S. et al., Hedgehog inhibition promotes a switch from Type II to Type I cell death receptor signaling in cancer cells. PLoS One, 6(3), 2011, e18330.
64. Chandler, J.M., Cohen, G.M., MacFarlane, M., Different subcellular distribution of caspase-3 and caspase-7 following Fas-induced apoptosis in mouse liver. J. Biol. Chem. 273:18 (1998), 10815–10818.
65. Zhivotovsky, B. et al., Caspases: their intracellular localization and translocation during apoptosis. Cell Death Differ. 6:7 (1999), 644–651.
66. Heinrich, M. et al., Cathepsin D targeted by acid sphingomyelinase-derived ceramide. EMBO J. 18:19 (1999), 5252–5263.
67. Heinrich, M. et al., Cathepsin D links TNF-induced acid sphingomyelinase to Bid-mediated caspase-9 and -3 activation. Cell Death Differ. 11:5 (2004), 550–563.
68. Barnhart, B.C., Alappat, E.C., Peter, M.E., The CD95 type I/type II model. Semin. Immunol. 15:3 (2003), 185–193.
69. Vande Walle, L., Lamkanfi, M., Vandenabeele, P., The mitochondrial serine protease HtrA2/Omi: an overview. Cell Death Differ. 15:3 (2008), 453–460.
70. Vaux, D.L., Silke, J., IAPs, RINGs and ubiquitylation. Nat. Rev. Mol. Cell Biol. 6:4 (2005), 287–297.
71. Vince, J.E. et al., IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis. Cell 131:4 (2007), 682–693.
72. Sosna, J. et al., The proteases HtrA2/Omi and UCH-L1 regulate TNF-induced necroptosis. Cell Commun. Signal., 11, 2013, 76.
73. Vancompernolle, K. et al., Atractyloside-induced release of cathepsin B, a protease with caspase-processing activity. FEBS Lett. 438:3 (1998), 150–158.
74. Roberg, K., Ollinger, K., Oxidative stress causes relocation of the lysosomal enzyme cathepsin D with ensuing apoptosis in neonatal rat cardiomyocytes. Am. J. Pathol. 152:5 (1998), 1151–1156.
75. Johansson, A.C. et al., Cathepsin D mediates cytochrome c release and caspase activation in human fibroblast apoptosis induced by staurosporine. Cell Death Differ. 10:11 (2003), 1253–1259.
76. Johansson, A.C. et al., Regulation of apoptosis-associated lysosomal membrane permeabilization. Apoptosis 15:5 (2010), 527–540.
77. Miura, Y. et al., Translocation of lysosomal cathepsin D caused by oxidative stress or proteasome inhibition in primary cultured neurons and astrocytes. Biol. Pharm. Bull. 33:1 (2010), 22–28.
78. Schafer, F.Q., Buettner, G.R., Acidic pH amplifies iron-mediated lipid peroxidation in cells. Free Radic. Biol. Med. 28:8 (2000), 1175–1181.
79. Guicciardi, M.E. et al., Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J. Clin. Invest. 106:9 (2000), 1127–1137.
80. Siskind, L.J., Kolesnick, R.N., Colombini, M., Ceramide channels increase the permeability of the mitochondrial outer membrane to small proteins. J. Biol. Chem. 277:30 (2002), 26796–26803.
81. Colombini, M., Ceramide channels and mitochondrial outer membrane permeability. J. Bioenerg. Biomembr. 49:1 (2017), 57–64.
82. Ullio, C. et al., Sphingosine mediates TNFalpha-induced lysosomal membrane permeabilization and ensuing programmed cell death in hepatoma cells. J. Lipid Res. 53:6 (2012), 1134–1143.
83. Conus, S. et al., Caspase-8 is activated by cathepsin D initiating neutrophil apoptosis during the resolution of inflammation. J. Exp. Med. 205:3 (2008), 685–698.
84. Droga-Mazovec, G. et al., Cysteine cathepsins trigger caspase-dependent cell death through cleavage of bid and antiapoptotic Bcl-2 homologues. J. Biol. Chem. 283:27 (2008), 19140–19150.
85. Duffy, M.J. et al., Role of ADAMs in cancer formation and progression. Clin. Cancer Res. 15:4 (2009), 1140–1144.
86. Duffy, M.J. et al., The ADAMs family of proteases: new biomarkers and therapeutic targets for cancer?. Clin. Proteomics, 8(1), 2011, 9.
87. Hofer, T.P. et al., Tissue-specific induction of ADAMTS2 in monocytes and macrophages by glucocorticoids. J. Mol. Med. (Berl.) 86:3 (2008), 323–332.
88. Mentrup, T., Fluhrer, R., Schroder, B., Latest emerging functions of SPP/SPPL intramembrane proteases. Eur. J. Cell Biol., 2017.
89. Behnke, J. et al., Signal-peptide-peptidase-like 2a (SPPL2a) is targeted to lysosomes/late endosomes by a tyrosine motif in its C-terminal tail. FEBS Lett. 585:19 (2011), 2951–2957.
90. Schneppenheim, J. et al., The intramembrane protease SPPL2a promotes B cell development and controls endosomal traffic by cleavage of the invariant chain. J. Exp. Med. 210:1 (2013), 41–58.
91. Ono, Y., Sorimachi, H., Calpains: an elaborate proteolytic system. Biochim. Biophys. Acta 1824:1 (2012), 224–236.
92. Sorimachi, H., Mamitsuka, H., Ono, Y., Understanding the substrate specificity of conventional calpains. Biol. Chem. 393:9 (2012), 853–871.
93. Osako, Y. et al., Autolytic activity of human calpain 7 is enhanced by ESCRT-III-related protein IST1 through MIT-MIM interaction. FEBS J. 277:21 (2010), 4412–4426.
94. Maemoto, Y. et al., Analysis of limited proteolytic activity of calpain-7 using non-physiological substrates in mammalian cells. FEBS J. 280:11 (2013), 2594–2607.
95. Grassme, H. et al., Ceramide-mediated clustering is required for CD95-DISC formation. Oncogene 22:35 (2003), 5457–5470.
96. Crawford, E.D. et al., The DegraBase: a database of proteolysis in healthy and apoptotic human cells. Mol. Cell. Proteomics 12:3 (2013), 813–824.
97. Julien, O., Wells, J.A., Caspases and their substrates. Cell Death Differ., 2017.
98. Julien, O. et al., Quantitative MS-based enzymology of caspases reveals distinct protein substrate specificities, hierarchies, and cellular roles. Proc. Natl. Acad. Sci. U. S. A. 113:14 (2016), E2001–10.
99. Moretti, D. et al., Calpains and cancer: friends or enemies?. Arch. Biochem. Biophys. 564 (2014), 26–36.
100. Sosna, J. et al., TNF-induced necroptosis and PARP-1-mediated necrosis represent distinct routes to programmed necrotic cell death. Cell. Mol. Life Sci. 71:2 (2014), 331–348.
101. Grassme, H. et al., CD95 signaling via ceramide-rich membrane rafts. J. Biol. Chem. 276:23 (2001), 20589–20596.